TWC
MRVI icon

TD Waterhouse Canada’s Maravai LifeSciences MRVI Stock Holding History

TD Waterhouse Canada’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$3.16K – 1884
2023
Q4 		$3.16K Buy
+500
New +$3.23K ﹤0.01% 1439
2022
Q2 		– Sell
-1,150
Closed -$40.5K – 1794
2022
Q1 		$40.5K Sell
1,150
-29,150
-96% -$977K ﹤0.01% 1036
2021
Q4 		$1.07M Buy
+30,300
New +$1.23M 0.01% 467

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TD Waterhouse Canada's MRVI Position: Q1 2024 in Review

TD Waterhouse Canada sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 500 shares — an estimated $3.16K sold.

TD Waterhouse Canada first reported a position in MRVI in Q4 2021 and held it in 3 quarters. The position peaked at $1.07M in Q4 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • TD Waterhouse Canada reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 500 Maravai LifeSciences shares in Q1 2024, an estimated $3.16K.
  • TD Waterhouse Canada first reported a position in Maravai LifeSciences in Q4 2021 and held it in 3 quarters.
  • TD Waterhouse Canada's Maravai LifeSciences position peaked at $1.07M in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on TD Waterhouse Canada's 13F filing for Q1 2024, filed 10 May 2024.